Factors Associated with Hyperpolypharmacy and Complex Medication Regimens in Kidney Transplant Recipients

• Published in: Journal of clinical medicine 2024-06, Vol.13 (13), p.3716
• Main Authors: Atić, Armin, Matijašević Škerlj, Jasmina, Jurić, Ivana, Katalinić, Lea, Furić Čunko, Vesna, Kljajić, Marina, Sabljić, Zoran, Jelaković, Bojan, Bašić-Jukić, Nikolina
• Format: Article
• Language: English
• Subjects: Body mass index; Chronic illnesses; Comorbidity; Diabetes; Diuretics; Drug dosages; Drug interactions; Hemodialysis; Hypertension; Information systems; Kidney diseases; Kidney transplants; Missing data; Mortality; Patients; Peritoneal dialysis; Polypharmacy; Quality of life; Renal replacement therapy; Statistical analysis; Variables
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13133716

: Kidney transplantation is considered the best modality for renal replacement therapy. The use of immunosuppressive therapy and pre-existing and newly developed comorbidities predispose these patients to the use of a large number of medications. (Hyper)polypharmacy is associated with worse adherence and negative outcomes. This study aims to explore the factors correlated with hyperpolypharmacy and complex medication regimens in kidney transplant recipients. : This is a cross-sectional study of outpatient kidney transplant recipients. Collected data include demographic data, complete chronic medication lists, medical history, and graft function. Linear and logistic regression were used to identify factors associated with hyperpolypharmacy and complex medication regimens. Medication regimen complexity was quantified by the Medication Regimen Complexity Index (MRCI). : Overall, 224 kidney transplant recipients were included, with an average time since transplantation of 8 years. Hyperpolypharmacy was present in more than two-thirds of patients; the average number of different medications was 12; and the mean MRCI score was 21.4, ranging from 6 to 50. Hypertension was almost universally present, while other frequently prescribed medication groups were hypolipemics, medication for bone-mineral metabolism disorders, gout, and antihyperglycemics. : Factors independently associated with hyperpolypharmacy and complex medication regimens were found to be age and graft function. Studies investigating interventions aimed at reducing medication complexity and increasing adherence should focus on older patients with worse graft function.